Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published May 14, 2014

Oasis TEARS Eye Drops Recall: Missing Label Hazard

Oasis Medical recalls 10,549 bottles of Oasis TEARS lubricant eye drops due to missing labels on the immediate bottle. Check your lot number and expiry date.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1347-2014DrugOasis Medical ›
Take action

Contact the company

Recalling firmOasis Medical Inc514 S Vermont Ave Bldg 510-528 · Glendora, CA 91741-6205
✎ GovInfoNow plain-language explainer

Oasis Medical, Inc. is recalling 10,549 bottles of Oasis TEARS Lubricant Eye Drops because the label on the immediate bottle is missing. This issue affects units distributed nationwide in the US. The specific remedy for consumers has not been stated in this record. Read more at govinfonow.com/recall/46070-oasis-medical-inc-recalls-oasis-tears-lubricant-eye-drops-10ml.

Source Summary by GovInfoNow · govinfonow.com/recall/46070-oasis-medical-inc-recalls-oasis-tears-lubricant-eye-drops-10ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-1347-2014

Cite this page

“Oasis TEARS Eye Drops Recall: Missing Label Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46070-oasis-medical-inc-recalls-oasis-tears-lubricant-eye-drops-10ml. Based on FDA recall #D-1347-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1347-2014%22&limit=1).

The FDA announced on May 14, 2014, that Oasis Medical Inc. is recalling Oasis TEARS Lubricant Eye Drops due to missing labels on the immediate bottle. The agency classified the Class III recall as voluntary and initiated by the firm.

How to tell if you have it

  • Oasis TEARS Lubricant Eye Drops
  • 10mL/0.3 fl. oz. Bottle
  • UPC: 8 54819 00002 3
  • Lot #: OTM-07
  • Expiry: 12/2015

The hazard

The hazard involves missing labels on the immediate bottle of the product. The FDA stated that the label on the immediate bottle is missing.

Context

GovInfoNow's records show Oasis Medical, Inc. has 4 other recalls on record since 2015-04-10. Other recent recalls of similar products include Sterile Lubricant Dry Eye Relief Eye Drops (2026-09-11), Haleon Parodontax Mouthwash (2025-12-26), and American Regent Levocarnitine Injection (2026-04-16).

How to tell if you have this one

Check your bottle for the absence of a label on the immediate container. The recalled product is Oasis TEARS Lubricant Eye Drops, 10mL/0.3 fl. oz. bottles distributed by OASIS Medical, Inc. Look for Lot # OTM-07 and an Expiry date of 12/2015. The UPC code is 8 54819 00002 3.

  • Brand
    Oasis Medical
  • Product
    Oasis Medical Inc recalls Oasis TEARS, Lubricant Eye Drops, 10mL/0.3 fl. oz. Bottle, OTC Only. Distributed by: OASIS, OASIS Medical, Inc
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle of Oasis TEARS Lubricant Eye Drops has a missing label and matches Lot # OTM-07 with an expiry of 12/2015.

  2. Contact Manufacturer

    Since the remedy is not stated in the record, contact Oasis Medical, Inc. directly for instructions on how to proceed with the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: May 14, 201412. FDA classified it Class III: May 22, 201423. Published in FDA’s Enforcement Report: May 28, 201434. FDA terminated the recall: Dec 17, 201442014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Oasis Tears PF Eye Drops Recall: Lack of Sterility Assurance
Oasis MedicalHealthy Living Acetaminophen Tablets Recall: Missing Manufacturer Label
Aurobindo PharmaRecall: Sterile Lubricant Dry Eye Relief Eye Drops - Sterility Risk
Leader / TopCare / Crocodile TearsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, Inc

Latest drug recalls

Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1347-2014 (May 14, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1347-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA